Covered recipient · General Payments record
EVERETT E VOKES
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$300,599.50
- Reported across 360 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $14,693.75 | 5 |
| Travel and Lodging | $10,019.53 | 6 |
| Food and Beverage | $705.32 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BioNTech SE | $16,212.92 | 10 |
| Genmab U.S., Inc. | $6,140.05 | 7 |
| AstraZeneca UK Limited | $1,662.50 | 2 |
| ABBVIE INC. | $1,268.75 | 1 |
| Acerta Pharma LLC | $134.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1,268.75 | 09/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106290960 | CMS |
| AstraZeneca Pharmaceuticals LP | $134.38 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104780492 | CMS |
| AstraZeneca UK Limited | $665.00 | 09/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093944892 | CMS |
| AstraZeneca UK Limited | $997.50 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094005098 | CMS |
| BioNTech SE | $125.00 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150660466 | CMS |
| BioNTech SE | $245.70 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150660358 | CMS |
| BioNTech SE | $504.45 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150660360 | CMS |
| BioNTech SE | $8,922.42 | 10/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150660362 | CMS |
| BioNTech SE | $72.70 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150660456 | CMS |
| BioNTech SE | $25.11 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150660458 | CMS |
| BioNTech SE | $25.11 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150660460 | CMS |
| BioNTech SE | $48.04 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150660462 | CMS |
| BioNTech SE | $81.89 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150660464 | CMS |
| BioNTech SE | $6,162.50 | 10/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150660568 | CMS |
| Genmab U.S., Inc. | $86.70 | 08/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126826500 | CMS |
| Genmab U.S., Inc. | $194.26 | 08/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126826502 | CMS |
| Genmab U.S., Inc. | $77.23 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826506 | CMS |
| Genmab U.S., Inc. | $66.00 | 08/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1126826498 | CMS |
| Genmab U.S., Inc. | $65.07 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826504 | CMS |
| Genmab U.S., Inc. | $50.79 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126826510 | CMS |
| Genmab U.S., Inc. | $5,600.00 | 08/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1126826508 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.